Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 2:01 AM
Ignite Modification Date:
2025-12-25 @ 2:01 AM
NCT ID:
NCT02540460
Brief Summary:
The purpose of this study is to investigate the population pharmacokinetics of LCB01-0371 after a multiple oral dose in healthy male subjects.
To investigate safety, tolerability of LCB01-0371 after a multiple oral dose in healthy male subjects.
Detailed Description:
Double blind, randomized, placebo control, multiple dose, dose escalation study
Study:
NCT02540460
Study Brief:
Protocol Section:
NCT02540460